Characterize Emerging HIV Strains from Blood Donors and Patients

Information

  • Research Project
  • 8556625
  • ApplicationId
    8556625
  • Core Project Number
    Y01AI012013
  • Full Project Number
    AAI12013001-1-0-1
  • Serial Number
  • FOA Number
  • Sub Project Id
  • Project Start Date
    -
  • Project End Date
    -
  • Program Officer Name
  • Budget Start Date
    -
  • Budget End Date
    -
  • Fiscal Year
    2012
  • Support Year
  • Suffix
  • Award Notice Date
    -

Characterize Emerging HIV Strains from Blood Donors and Patients

The FDA laboratory on HIV sequence analysis and biologic characterization (co-receptor usage) is conducting studies to characterize viruses/plasma from blood bank and diagnostic settings in Cameroon. New strains or plasma will be contributed to the NIAID for the development of a variant panel that may be useful in vaccine studies and to the manufacturers of HIV blood screening, diagnostic and monitoring assays.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    Y01
  • Administering IC
    AI
  • Application Type
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    140000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:140000\
  • Funding Mechanism
    INTERAGENCY AGREEMENTS
  • Study Section
  • Study Section Name
  • Organization Name
    NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Organization Department
  • Organization DUNS
  • Organization City
  • Organization State
  • Organization Country
  • Organization Zip Code
  • Organization District